WILLIAM LIZARRAGA: Open Payments
NPI 1538385091 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,198 in 125 payments from 20 companies in 2025. Trend: 2023 $2,607 · 2024 $3,386 · 2025 $2,198
Food & beverage: $2,198
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 28 | $474 |
| Lilly USA, LLC | 20 | $294 |
| Novo Nordisk Inc | 17 | $292 |
| AstraZeneca Pharmaceuticals LP | 6 | $145 |
| GlaxoSmithKline, LLC. | 8 | $128 |
| ABBVIE INC. | 5 | $120 |
| Abbott Laboratories | 6 | $99 |
| Aimmune Therapeutics, Inc. | 6 | $88 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $88 |
| Otsuka America Pharmaceutical, Inc. | 4 | $79 |
Products named: ELIQUIS, MOUNJARO, PREVNAR 20, JARDIANCE, TRELEGY ELLIPTA, Ozempic, FREESTYLE LIBRE 3, NURTEC ODT.
Industry payments across TN — which companies pay providers there.
